| Composition : |
Each un-coated tablet contains Metronidazole 250 mg. |
| Indications : |
- Prevention of post-operative infections due to anaerobic bacteria, particularly species of bacteroids and anaerobic streptococci.
- The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis and post-operative wound infections from which pathogenic anaerobes have been isolated.
- Urogenital trichomoniasis in the female (Trichomonas vaginalis), and in man.
- Bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or Gardnerella vaginalis).
- All forms of amoebiasis (intestinal and extra-intestinal disease and asymptomatic cyst passers).
- Giardiasis.
- Acute ulcerative gingivitis.
- Acute dental infections (eg acute pericoronitis and acute apical infections)
- Anaerobically-infected leg ulcers and pressure sores.
- Treatment of Helicobacter pylori infection associated with peptic ulcer as part of triple therapy.
|
| Contraindications : |
Known hypersensitivity to Metronidazole or any of the ingredients.
Pregnancy - Metronidazole should not be used in the first trimester in patients with trichomoniasis or bacterial vaginosis.
Breast feeding should be discontinued for 12-24 hours when single high dose (e.g. 2g) therapy is used
|
| Adverse Effects : |
Headache, abdominal pain, constipation, diarrhoea, flatulence, metallic taste and nausea/vomiting |
| Dosage : |
250 mg or 500 mg twice daily for 5 to 10 days depending on the type of infection.
|
